Gene therapy for the treatment of catecholaminergic polymorphic ventricular tachycardia.
作者信息
Hajjar Roger J, Lyon Alexander R
机构信息
From the Cardiovascular Research Center, Icahn School of Medicine at Mount Sinai, New York, NY (R.J.H.); and NIHR Cardiovascular Biomedical Research Unit, Royal Brompton Hospital and Imperial College, London, UK (A.R.L.).
出版信息
Circulation. 2014 Jun 24;129(25):2633-5. doi: 10.1161/CIRCULATIONAHA.114.010586. Epub 2014 Jun 2.
Abstract
摘要
相似文献
1
Gene therapy for the treatment of catecholaminergic polymorphic ventricular tachycardia.用于治疗儿茶酚胺能多形性室性心动过速的基因疗法。
Circulation. 2014 Jun 24;129(25):2633-5. doi: 10.1161/CIRCULATIONAHA.114.010586. Epub 2014 Jun 2.
2
Single delivery of an adeno-associated viral construct to transfer the CASQ2 gene to knock-in mice affected by catecholaminergic polymorphic ventricular tachycardia is able to cure the disease from birth to advanced age.单次腺相关病毒载体传递 CASQ2 基因转染嵌合小鼠能够从出生到老年治愈儿茶酚胺多形性室性心动过速。
Circulation. 2014 Jun 24;129(25):2673-81. doi: 10.1161/CIRCULATIONAHA.113.006901. Epub 2014 Jun 2.
3
Catecholaminergic Polymorphic Ventricular Tachycardia.儿茶酚胺敏感性多形性室性心动过速。
Cardiol Rev. 2020 Nov/Dec;28(6):325-331. doi: 10.1097/CRD.0000000000000302.
4
Abnormal propagation of calcium waves and ultrastructural remodeling in recessive catecholaminergic polymorphic ventricular tachycardia.钙波异常传播和隐匿性儿茶酚胺多形性室性心动过速的超微结构重构。
Circ Res. 2013 Jul 5;113(2):142-52. doi: 10.1161/CIRCRESAHA.113.301783. Epub 2013 May 14.
5
Prevention of ventricular arrhythmia and calcium dysregulation in a catecholaminergic polymorphic ventricular tachycardia mouse model carrying calsequestrin-2 mutation.钙释放通道蛋白 2 突变致儿茶酚胺敏感性多形性室性心动过速小鼠模型中心律失常和钙稳态失衡的预防。
J Cardiovasc Electrophysiol. 2011 Mar;22(3):316-24. doi: 10.1111/j.1540-8167.2010.01877.x. Epub 2010 Aug 30.
6
Adeno-associated virus-mediated CASQ2 delivery rescues phenotypic alterations in a patient-specific model of recessive catecholaminergic polymorphic ventricular tachycardia.腺相关病毒介导的CASQ2递送可挽救隐性儿茶酚胺能多形性室性心动过速患者特异性模型中的表型改变。
Cell Death Dis. 2016 Oct 6;7(10):e2393. doi: 10.1038/cddis.2016.304.
7
Clinical utility gene card for: Catecholaminergic polymorphic ventricular tachycardia (CPVT).儿茶酚胺能多形性室性心动过速（CPVT）临床应用基因卡片
Eur J Hum Genet. 2014 Jan;22(1). doi: 10.1038/ejhg.2013.55. Epub 2013 Apr 3.
8
Catecholaminergic polymorphic ventricular tachycardia.儿茶酚胺能多形性室性心动过速
Prog Cardiovasc Dis. 2008 Jul-Aug;51(1):23-30. doi: 10.1016/j.pcad.2007.10.005.
9
Flecainide therapy suppresses exercise-induced ventricular arrhythmias in patients with CASQ2-associated catecholaminergic polymorphic ventricular tachycardia.氟卡尼治疗可抑制 CASQ2 相关儿茶酚胺敏感性多形性室性心动过速患者运动诱发的室性心律失常。
Heart Rhythm. 2013 Nov;10(11):1671-5. doi: 10.1016/j.hrthm.2013.08.011. Epub 2013 Aug 13.
10
Decreased RyR2 refractoriness determines myocardial synchronization of aberrant Ca2+ release in a genetic model of arrhythmia.RyR2 不应期缩短决定了心律失常基因模型中心肌异常钙释放的同步性。
Proc Natl Acad Sci U S A. 2013 Jun 18;110(25):10312-7. doi: 10.1073/pnas.1300052110. Epub 2013 Jun 3.
引用本文的文献
1
Catecholaminergic Polymorphic Ventricular Tachycardia and Gene Therapy: A Comprehensive Review of the Literature.儿茶酚胺能多形性室性心动过速与基因治疗：文献综述
Cureus. 2023 Oct 30;15(10):e47974. doi: 10.7759/cureus.47974. eCollection 2023 Oct.
2
Catecholaminergic Polymorphic Ventricular Tachycardia.儿茶酚胺能多形性室性心动过速
Arrhythm Electrophysiol Rev. 2022 Apr;11:e20. doi: 10.15420/aer.2022.09.
3
Conditional ablation and conditional rescue models for Casq2 elucidate the role of development and of cell-type specific expression of Casq2 in the CPVT2 phenotype.条件性敲除和条件性拯救 Casq2 模型阐明了 Casq2 在 CPVT2 表型中的发育和细胞类型特异性表达的作用。
Hum Mol Genet. 2018 May 1;27(9):1533-1544. doi: 10.1093/hmg/ddy060.
4
Catecholaminergic polymorphic ventricular tachycardia: An exciting new era.儿茶酚胺能多形性室性心动过速：一个令人兴奋的新时代。
Ann Pediatr Cardiol. 2016 May-Aug;9(2):137-46. doi: 10.4103/0974-2069.180645.
本文引用的文献
1
Single delivery of an adeno-associated viral construct to transfer the CASQ2 gene to knock-in mice affected by catecholaminergic polymorphic ventricular tachycardia is able to cure the disease from birth to advanced age.单次腺相关病毒载体传递 CASQ2 基因转染嵌合小鼠能够从出生到老年治愈儿茶酚胺多形性室性心动过速。
Circulation. 2014 Jun 24;129(25):2673-81. doi: 10.1161/CIRCULATIONAHA.113.006901. Epub 2014 Jun 2.
2
Outcomes of defibrillator therapy in catecholaminergic polymorphic ventricular tachycardia.儿茶酚胺能多形性室性心动过速的除颤治疗结果
Heart Rhythm. 2014 Jan;11(1):58-66. doi: 10.1016/j.hrthm.2013.10.027. Epub 2013 Oct 11.
3
Long-term effects of AAV1/SERCA2a gene transfer in patients with severe heart failure: analysis of recurrent cardiovascular events and mortality.AAV1/SERCA2a 基因转导治疗严重心力衰竭患者的长期疗效：心血管事件再发和死亡率分析。
Circ Res. 2014 Jan 3;114(1):101-8. doi: 10.1161/CIRCRESAHA.113.302421. Epub 2013 Sep 24.
4
Regulatory evaluation of Glybera in Europe - two committees, one mission.欧洲对 Glybera 的监管评估——两个委员会，一项使命。
Nat Rev Drug Discov. 2013 Sep;12(9):719. doi: 10.1038/nrd3835-c1. Epub 2013 Aug 19.
5
Catecholaminergic polymorphic ventricular tachycardia: from bench to bedside.儿茶酚胺能多形性室性心动过速：从实验室到临床
Heart. 2013 Apr;99(7):497-504. doi: 10.1136/heartjnl-2012-302033. Epub 2013 Feb 6.
6
Flecainide reduces Ca(2+) spark and wave frequency via inhibition of the sarcolemmal sodium current.氟卡尼通过抑制肌膜钠电流减少 Ca(2+) 火花和波频率。
Cardiovasc Res. 2013 May 1;98(2):286-96. doi: 10.1093/cvr/cvt012. Epub 2013 Jan 19.
7
Calcium Upregulation by Percutaneous Administration of Gene Therapy in Cardiac Disease (CUPID): a phase 2 trial of intracoronary gene therapy of sarcoplasmic reticulum Ca2+-ATPase in patients with advanced heart failure.经皮基因治疗增强心肌钙（CUPID）：晚期心力衰竭患者冠状动脉内肌浆网 Ca2+-ATP 酶基因治疗的 2 期试验。
Circulation. 2011 Jul 19;124(3):304-13. doi: 10.1161/CIRCULATIONAHA.111.022889. Epub 2011 Jun 27.
8
Flecainide prevents catecholaminergic polymorphic ventricular tachycardia in mice and humans.氟卡尼可预防小鼠和人类的儿茶酚胺能多形性室性心动过速。
Nat Med. 2009 Apr;15(4):380-3. doi: 10.1038/nm.1942. Epub 2009 Mar 29.
9
Stable myocardial-specific AAV6-S100A1 gene therapy results in chronic functional heart failure rescue.稳定的心肌特异性腺相关病毒6型-S100A1基因治疗可实现慢性功能性心力衰竭的挽救。
Circulation. 2007 May 15;115(19):2506-15. doi: 10.1161/CIRCULATIONAHA.106.671701. Epub 2007 Apr 30.
10
Mechanisms of abnormal calcium homeostasis in mutations responsible for catecholaminergic polymorphic ventricular tachycardia.儿茶酚胺能多形性室性心动过速相关突变中异常钙稳态的机制
Circ Res. 2007 Feb 2;100(2):e22-31. doi: 10.1161/01.RES.0000258468.31815.42. Epub 2007 Jan 18.
Zotero 插件